Advances in research on location-specific heterogeneity in the etiology, prognosis, and treatment of intracerebral hemorrhage
Intracerebral hemorrhage (ICH) is a devastating subtype of stroke associated with high rates of mortality, long-term disability, and recurrence. Growing evidence indicates that hemorrhage location is closely associated with differences in underlying vascular pathology, disease progression, clinical outcomes, and treatment response. This narrative review critically synthesizes current evidence on location-specific heterogeneity in spontaneous ICH, encompassing etiology, hematoma expansion, intraventricular extension, hydrocephalus, functional outcomes, recurrence, and therapeutic management. Deep ICH is predominantly associated with hypertensive small vessel disease, whereas lobar and superficial cerebellar hemorrhages are more frequently linked to cerebral amyloid angiopathy. Although location-related differences in hematoma expansion have been reported, findings remain inconsistent owing to variations in outcome definitions, imaging timing, patient characteristics, and study methodology. Hemorrhage location is also associated with differences in the prognostic significance of hematoma volume, susceptibility to ventricular extension and hydrocephalus, and patterns of neurological and cognitive recovery. Lobar ICH generally carries a higher risk of recurrence, particularly in the presence of cerebral amyloid angiopathy-related imaging markers. Emerging evidence further suggests that hemorrhage location may influence responses to acute blood pressure management and the risk–benefit balance of antithrombotic therapy. However, much of the available evidence derives from observational studies and secondary analyses, and robust evidence supporting location-specific therapeutic strategies remains limited. Collectively, these findings highlight hemorrhage location as an important dimension of ICH heterogeneity that may complement established clinical and imaging parameters in prognostic assessment and individualized management. Future prospective investigations and adequately powered, location-stratified randomized controlled trials are warranted to establish whether integrating anatomical location into clinical decision-making improves patient outcomes.
Authors
- Quandan Tan (ORCID: https://orcid.org/0000-0003-1656-0400)
- Yujie Tang (ORCID: https://orcid.org/0009-0000-6781-2466)
- Yapeng Lin (ORCID: https://orcid.org/0000-0001-6303-2964)
- Chaochen Yin
- Yuetong Luo
- Ruijuan Gang
- Xianshi Yang
- Yanda Yang
- Qi Wang
- Qi Lin
- Chenlin Hu
- Pengyuan Wang
- Xindong Liu
- Jingwen Xia
- Linjie Xie
- Baiyuan Yang
- Jin Zhao
- Rong Wang
- Yong Shi
- Yan Chen
Institutions
- Huaihua University (CN)
- University of Electronic Science and Technology of China (CN)
- Chengdu Medical College (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
- Chengdu Second People's Hospital (CN)
- Shanghai University of Medicine and Health Sciences (CN)
- Hua Medicine (China) (CN)
- Chengdu Seventh People's Hospital (CN)
- Hunan University of Medicine (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fneur.2026.1978123
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chengdu Medical College
- Health Commission of Sichuan Province